EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
49 hedge funds and large institutions have $508M invested in Evelo Biosciences, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
0.87%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
9
Increased
24
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.8M |
| 2 |
BlackRock
New York
|
+$4.37M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.23M |
| 4 |
AG
Artal Group
Luxembourg
|
+$2.72M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.37M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$6.85M |
| 2 |
Millennium Management
New York
|
-$1.36M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$177K |
| 4 |
CCM
CAAS Capital Management
New York
|
-$173K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$160K |
